EU: New safety features against falsified medicines

29 February 2016

A delegated regulation introduces obligatory ‘safety features’ for medicines in the form of a unique identifier and an anti-tampering device. Such safety features will protect European citizens against the health threat of falsified medicines, which may contain ingredients, including active ingredients, which are of low quality or in the wrong dosage. The safety features will guarantee medicine authenticity for the benefit of patients and businesses, and will strengthen the security of the medicine supply chain. The act in question supplements the Falsified Medicines Directive (2011/62/EU), and will be applicable from 9 February 2019 (EC Public Health Newsletter, 9 February 2016).
Click here for the full news item.
Click here for Commission Delegated Regulation (EU) 2016/161.
Click here for more information about falsified medicines legislation.
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

If you have any questions about this subject, please contact us: info@nvc.nl, +31-(0)182-512411. This item is also included in our monthly overview, the NVC Members-only Update.